Page 71 - பல்கலைக்கழகம் ஆஃப் ஸ்ட்ராஸ்பர்க் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Both management teams were committed to this mission, and even before the completion of the combination documentation, transition of our organizations began by my appointment to the Enzolytics Board as a Director and CEO and appointment of Harry Zhabilov to the BCLS Board. This allowed us to share information for assimilating our proprietary information for research and development purposes and for streamlining the administrative function to accelerate future growth. On December 1, 2020, the combination agreement was completed, and the control block of shares of Enzolytics was transferred in accordance with the terms of the final document to Dr. Joseph Cotropia, Dr. Gaurav Chandra, and me, officially integrating the management teams and organizations into one single-purposed organization.

United statesSouth africaUnited kingdomGaurav chandraJoseph cotropiaHarry zhabilovRonald mossCharles cotropiaNational centerWhile enzolytics incUniversity of strasbourgUniversity institute for preclinicalTexasam universityBioclonetics immunotherapeutics incDrug administrationResearch center